Fundraising FoxHatteras Venture Partners — 2026 Investments
5 investments dated 2026 · listed companies and verified rows first · show all
AN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders.
BiotechHealthtechMenlo Park, US
Joseph S. Zakrzewski(Co-Founder & Director)Eric Easom(Co-Founder, President & CEO)inGeorge H. Talbot(Co-Founder & Senior Clinical Advisor)Michael R.K. (Dickon) Alley(Co-Founder, SVP Research Fellow, Head of Biology)Sanjay Chanda(Chief Development Officer)inLucy O. Day(Chief Financial Officer)in
Co-investorsAdjuvant CapitalBioRock VenturesFlucas VenturesMountain Group CapitalRA CapitalBiotechnology Value Fund
Ladder Health provides digital health services focused on pediatric care and developmental screening, helping families navigate healthcare options for their children.
Digital HealthHealthtechBoston, US
Elizabeth Kidderin
Co-investors25MadisonGROOVE CAPITALJumpstart CapitalMairs & Power VCNina CapitalCREATE HEALTH VENTURES
CREATE Medicines develops in vivo CAR immunotherapy using proprietary mRNA-LNP technology to program T cells, NK cells, and myeloid cells directly within the body for cancer, autoimmunity, and fibrosis.
AI & Machine LearningBiotechHealthtechMedical DevicesCambridge, US
Daniel Getts, Ph.D.(Chief Executive Officer, Cofounder, Board Director)
Co-investorsARCH Venture Partners8VCAlexandriaNewpath Partners
Pharaoh Neuro is a neurotechnology company focused on protecting and restoring brain health, with an emphasis on the fluids surrounding the brain such as cerebrospinal fluid.
BiotechDeep TechHealthtechMedical Devices
Mark Wagner(Founder, Investor, & Director in Pharaoh)inDr. Nandan Lad(Chief Medical Officer & Co-Founder)Rich Nazarian(Founder, Investor, & Director in Pharaoh)inAmaza Reitmeier(Chief Executive Officer, Director)in
Co-investorsArboretum VenturesIAG Capital PartnersLaerdal Million Lives Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.